https://www.jelmyto.com/patient/resources/
JELMYTO® (mitomycin) for pyelocalyceal solution
JELMYTO is the first and only FDA-approved treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients
mitomycinpyelocalycealsolution
https://www.jelmyto.com/hcp/clinical-information/adverse-reactions/
Adverse Reactions | JELMYTO® (mitomycin) for pyelocalyceal solution
JELMYTO is the first and only FDA-approved treatment for low-grade upper tract urothelial cancer (LG-UTUC) in adult patients.
adverse reactionsmitomycinpyelocalycealsolution